influenza
viru
highli
transmiss
caus
mild
sever
ill
includ
high
fever
headach
myalgia
pneumonia
annual
influenza
epidem
worldwid
caus
approxim
three
five
million
case
sever
ill
death
everi
year
result
great
social
econom
burden
influenza
estim
billion
per
year
unit
influenza
vaccin
one
effect
measur
prevent
influenza
viru
infect
mainli
produc
embryon
chicken
egg
howev
influenza
virus
propag
egg
frequent
acquir
antigen
alter
host
chang
would
pose
seriou
challeng
owe
reduct
vaccin
effect
vaccin
potenti
solv
problem
antigen
chang
associ
egg
adapt
vaccin
seed
virus
vaccin
prepar
clinic
specimen
cell
cultur
howev
clinic
sampl
risk
harbor
respiratori
virus
influenza
virus
moreov
mammalian
cell
might
amplifi
contamin
human
virus
easili
embryon
chicken
egg
owe
host
similar
therefor
necessari
investig
pattern
present
clinic
sampl
explor
whether
cell
cultur
technolog
select
propag
influenza
virus
sampl
contain
respiratori
virus
propag
influenza
virus
cell
line
canin
kidney
mdck
cell
vero
cell
cell
cell
commonli
use
mdck
cell
line
establish
kidney
healthi
cocker
spaniel
dog
long
histori
studi
influenza
virus
convent
mdck
cell
adher
growth
good
candid
prepar
vaccin
seed
virus
sinc
support
effici
growth
human
influenza
suspens
cell
line
design
paper
first
develop
util
produc
season
influenza
suspens
cell
superior
adher
cell
owe
follow
advantag
simpler
cultur
process
without
bead
lower
cost
higher
viru
yield
therefor
could
suitabl
substrat
influenza
vaccin
seed
prepar
establish
kidney
healthi
rhesu
monkey
also
use
propag
varieti
virus
includ
influenza
proven
nude
mice
free
specif
adventiti
agent
cell
line
could
promis
candid
prepar
vaccin
seed
virus
sinc
safeti
confirm
use
practic
applic
littl
delay
studi
analyz
pattern
respiratori
virus
clinic
specimen
evalu
abil
cell
propag
influenza
virus
elimin
respiratori
virus
select
clinic
specimen
patient
diagnos
influenza
ill
base
clinic
symptom
andor
result
rapid
test
influenza
patient
visit
hospit
influenza
season
januari
may
influenza
season
decemb
april
influenza
season
septemb
februari
japan
nasal
pharyng
sampl
collect
use
utm
kit
copan
italia
brescia
itali
transport
medium
consist
minimum
essenti
medium
mem
supplement
gelatin
unitsml
penicillin
streptomycin
specimen
aliquot
store
use
studi
protocol
approv
ethic
committe
nation
institut
infecti
diseas
japan
cell
cultur
dispos
spinner
flask
corn
corn
ny
usa
ml
chemic
defin
medium
cdm
rpm
shake
platform
sanyo
osaka
japan
cell
subcultur
mem
supplement
fetal
bovin
serum
fb
cultur
flask
adventiti
specimen
inocul
cultur
cell
viru
isol
use
infect
medium
prepar
neomycin
gibco
carlsbad
ca
usa
prevent
bacteri
contamin
specimen
trypzean
st
loui
mo
usa
support
viral
growth
densiti
infect
medium
adjust
cellsml
ml
cell
suspens
distribut
tube
viru
isol
cell
cell
seed
dish
diamet
day
inocul
maintain
mem
fb
use
optipro
medium
contain
mm
neomycin
trypzean
trypsin
acetyl
use
prepar
viru
isol
medium
fifti
microlit
clinic
specimen
inocul
cultur
three
cell
line
incub
hour
supernat
harvest
passag
two
passag
resplex
ii
assay
perform
investig
presenc
absenc
influenza
respiratori
virus
viral
nucleic
acid
sampl
extract
use
qiaamp
minelut
viru
spin
kit
qiagen
gmbh
hilden
germani
qiaamp
viral
rna
mini
kit
qiagen
resplex
ii
kit
qiagen
use
accord
manufactur
instruct
detect
human
respiratori
virus
follow
respiratori
syncyti
viru
type
rsva
respiratori
syncyti
viru
type
b
rsvb
influenza
viru
infa
influenza
b
viru
infb
parainfluenza
viru
type
parainfluenza
viru
type
parainfluenza
viru
type
parainfluenza
viru
type
human
metapneumovirus
b
coxsackievirusechoviru
cvev
rhinoviru
rhv
adenoviru
type
b
advb
adenoviru
type
e
coronaviru
coronaviru
coronaviru
coronaviru
bocaviru
bocv
principl
assay
base
multiplex
combin
fluoresc
detect
specif
pcr
amplicon
liquichip
workstat
use
qiaplex
mdd
total
sampl
patient
diagnos
influenza
ill
analyz
respiratori
virus
use
resplex
ii
assay
number
sampl
posit
infa
infb
respiratori
virus
respect
doubl
infect
detect
sampl
tripl
infect
sampl
tabl
combin
virus
frequent
identifi
infa
infb
doubl
infect
group
sampl
infa
rhv
cvev
tripl
infect
group
sampl
examin
specif
pattern
correl
detect
virus
viru
pair
tabl
evalu
fisher
exact
test
tabl
addit
detect
rate
one
viru
background
anoth
sampl
compar
background
sampl
determin
whether
correl
posit
neg
identifi
four
pair
virus
signific
associ
p
show
neg
correl
exhibit
posit
correl
tabl
howev
influenza
virus
significantli
correl
respiratori
virus
result
suggest
infa
infb
would
mutual
interfer
infect
wherea
infect
influenza
virus
would
occur
independ
case
investig
whether
select
amplifi
influenza
viru
presenc
respiratori
virus
sampl
contain
influenza
viru
plu
virus
inocul
passag
three
cell
line
sampl
tripl
doubl
infect
could
select
allow
prolifer
influenza
virus
elimin
contamin
virus
tabl
particularli
isol
rate
influenza
virus
significantli
higher
virus
group
doubl
infect
infa
p
doubl
infect
infa
cvev
p
doubl
infect
infa
rhv
p
influenza
virus
isol
group
doubl
infect
doubl
infect
without
propag
adventiti
virus
howev
differ
detect
rate
influenza
viru
other
signific
doubl
infect
group
isol
cvev
obtain
four
specimen
although
influenza
viru
amplifi
cell
passag
examin
whether
elimin
contamin
virus
passag
clinic
specimen
contain
respiratori
virus
influenza
viru
three
cell
line
resplex
ii
assay
detect
respiratori
viru
sampl
cell
line
tabl
cvev
rhv
rsva
rsvb
elimin
cell
passag
irrespect
singl
doubl
infect
studi
use
resplex
ii
assay
analyz
specif
pattern
respiratori
virus
clinic
specimen
evalu
suitabl
three
cell
line
substrat
multipli
influenza
virus
select
brunstein
et
report
statist
relev
associ
particular
pathogen
posit
correl
neg
correl
result
reproduc
present
studi
moreov
newli
identifi
neg
associ
pair
posit
associ
pair
anticip
case
neg
correl
would
observ
frequent
first
viral
infect
would
activ
interferon
signal
interfer
second
viral
infect
howev
studi
detect
signific
influenza
virus
exhibit
remark
associ
respiratori
virus
one
possibl
explan
could
attenu
interferon
signal
viral
encod
protein
influenza
viru
also
possibl
requir
sampl
size
larger
present
studi
detect
signific
associ
influenza
virus
virus
result
suggest
influenza
viru
virus
clinic
specimen
ignor
would
thu
necessari
select
cell
substrat
elimin
contamin
virus
amplifi
influenza
virus
roth
et
al
report
mdck
cell
ident
cell
could
remov
adventiti
virus
propag
influenza
present
studi
analyz
properti
well
two
mdck
cell
line
show
differ
growth
phenotyp
suspens
cell
line
wherea
adher
cell
line
differ
suggest
dissimilar
pattern
glycosyl
protein
express
cell
surfac
consequ
expect
would
exhibit
differ
profil
viru
amplif
howev
show
result
cell
line
could
propag
influenza
virus
remov
adventiti
agent
multipl
infect
sampl
result
demonstr
could
good
cell
substrat
prepar
vaccin
seed
virus
regard
isol
rate
influenza
virus
n
wherea
statist
signific
differ
p
four
sampl
group
doubl
infect
contamin
cvev
erad
passag
wherea
one
cvev
isol
passag
result
indic
might
inferior
consid
low
abil
multipli
influenza
virus
elimin
contamin
virus
one
limit
studi
sampl
size
multipl
infect
group
small
larger
sampl
size
make
possibl
identifi
correl
among
virus
test
broader
pattern
multipl
infect
select
isol
influenza
virus
anoth
limit
lack
studi
determin
whether
viabl
virus
could
amplifi
upon
addit
passag
cell
cultur
techniqu
sometim
multipli
virus
even
sampl
respect
virus
includ
resplex
ii
kit
could
perform
test
pcr
detect
due
limit
clinic
specimen
report
adher
mdck
cell
show
growth
mump
virus
measl
virus
rubella
virus
herp
simplex
virus
cytomegalovirus
henc
seem
littl
risk
amplif
virus
passag
prepar
vaccin
seed
virus
revers
genet
use
well
clinic
specimen
novel
respiratori
viru
emerg
replic
well
mdck
cell
influenza
virus
might
difficult
prepar
seed
virus
clinic
specimen
situat
revers
genet
use
plasmid
viru
start
materi
produc
influenza
virus
virus
particularli
seriou
problem
low
replic
effici
embryon
hen
egg
critic
antigen
alter
egg
recent
approv
influenza
vaccin
seed
thu
expect
complet
vaccin
pave
way
overcom
difficulti
associ
vaccin
cell
determin
use
studi
prepar
vaccin
seed
virus
without
adventiti
agent
howev
new
influenza
virus
might
appear
lower
abil
replic
mdck
cell
line
situat
would
necessari
establish
cell
line
use
togeth
facilit
amplif
variabl
influenza
virus
use
cell
line
could
contribut
global
public
health
rapid
product
safe
effect
vaccin
